Loading…
Leflunomide-induced subacute cutaneous lupus erythematosus
Saved in:
Published in: | Rheumatology (Oxford, England) England), 2005-06, Vol.44 (6), p.823-824 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3 |
---|---|
cites | cdi_FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3 |
container_end_page | 824 |
container_issue | 6 |
container_start_page | 823 |
container_title | Rheumatology (Oxford, England) |
container_volume | 44 |
creator | Goëb, V. Berthelot, J. M. Joly, P. Mejjad, O. de Quatrebarbes, J. Reynaud-Hautin, C. Vittecoq, O. Le Loët, X. |
description | |
doi_str_mv | 10.1093/rheumatology/keh586 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_195682846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>857798361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3</originalsourceid><addsrcrecordid>eNpNkEtLw0AQxxdRbK1-AkGK9-g-so94k1atUPBSUXpZNtmJTZtH3c2C_fampFQvMwPzf8APoWuC7whO2L1bQahM25TN1-5-AyuuxAkakljQCDNGT483jQfowvs1xpgTps7RgHDJZSLiIXqYQ16GuqkKC1FR25CBHfuQmiy0MO6GqaEJflyGbTfB7doV7Et98JfoLDelh6vDHqH356fFZBbN315eJ4_zKIuxbCOrkhwIcMsZyFTZLM1yahQ3XKaYGGYSTgkIC5YksQRQlAumsGE5zrkBYCN02-duXfMdwLd63QRXd5WaJFwoqmLRiVgvylzjvYNcb11RGbfTBOs9Lv0fl-5xda6bQ3RIK7B_ngOfThD1gsK38HP8G7fRQjLJ9exzqRcf0-lyyidasl-Dlnvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195682846</pqid></control><display><type>article</type><title>Leflunomide-induced subacute cutaneous lupus erythematosus</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Goëb, V. ; Berthelot, J. M. ; Joly, P. ; Mejjad, O. ; de Quatrebarbes, J. ; Reynaud-Hautin, C. ; Vittecoq, O. ; Le Loët, X.</creator><creatorcontrib>Goëb, V. ; Berthelot, J. M. ; Joly, P. ; Mejjad, O. ; de Quatrebarbes, J. ; Reynaud-Hautin, C. ; Vittecoq, O. ; Le Loët, X.</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/keh586</identifier><identifier>PMID: 15757964</identifier><identifier>CODEN: BJRHDF</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antirheumatic Agents - adverse effects ; Arthritis, Rheumatoid - drug therapy ; Female ; Humans ; Isoxazoles - adverse effects ; Lupus Erythematosus, Cutaneous - chemically induced ; Middle Aged</subject><ispartof>Rheumatology (Oxford, England), 2005-06, Vol.44 (6), p.823-824</ispartof><rights>Copyright Oxford University Press(England) Jun 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3</citedby><cites>FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15757964$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goëb, V.</creatorcontrib><creatorcontrib>Berthelot, J. M.</creatorcontrib><creatorcontrib>Joly, P.</creatorcontrib><creatorcontrib>Mejjad, O.</creatorcontrib><creatorcontrib>de Quatrebarbes, J.</creatorcontrib><creatorcontrib>Reynaud-Hautin, C.</creatorcontrib><creatorcontrib>Vittecoq, O.</creatorcontrib><creatorcontrib>Le Loët, X.</creatorcontrib><title>Leflunomide-induced subacute cutaneous lupus erythematosus</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology</addtitle><subject>Antirheumatic Agents - adverse effects</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Isoxazoles - adverse effects</subject><subject>Lupus Erythematosus, Cutaneous - chemically induced</subject><subject>Middle Aged</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpNkEtLw0AQxxdRbK1-AkGK9-g-so94k1atUPBSUXpZNtmJTZtH3c2C_fampFQvMwPzf8APoWuC7whO2L1bQahM25TN1-5-AyuuxAkakljQCDNGT483jQfowvs1xpgTps7RgHDJZSLiIXqYQ16GuqkKC1FR25CBHfuQmiy0MO6GqaEJflyGbTfB7doV7Et98JfoLDelh6vDHqH356fFZBbN315eJ4_zKIuxbCOrkhwIcMsZyFTZLM1yahQ3XKaYGGYSTgkIC5YksQRQlAumsGE5zrkBYCN02-duXfMdwLd63QRXd5WaJFwoqmLRiVgvylzjvYNcb11RGbfTBOs9Lv0fl-5xda6bQ3RIK7B_ngOfThD1gsK38HP8G7fRQjLJ9exzqRcf0-lyyidasl-Dlnvo</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Goëb, V.</creator><creator>Berthelot, J. M.</creator><creator>Joly, P.</creator><creator>Mejjad, O.</creator><creator>de Quatrebarbes, J.</creator><creator>Reynaud-Hautin, C.</creator><creator>Vittecoq, O.</creator><creator>Le Loët, X.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20050601</creationdate><title>Leflunomide-induced subacute cutaneous lupus erythematosus</title><author>Goëb, V. ; Berthelot, J. M. ; Joly, P. ; Mejjad, O. ; de Quatrebarbes, J. ; Reynaud-Hautin, C. ; Vittecoq, O. ; Le Loët, X.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antirheumatic Agents - adverse effects</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Isoxazoles - adverse effects</topic><topic>Lupus Erythematosus, Cutaneous - chemically induced</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goëb, V.</creatorcontrib><creatorcontrib>Berthelot, J. M.</creatorcontrib><creatorcontrib>Joly, P.</creatorcontrib><creatorcontrib>Mejjad, O.</creatorcontrib><creatorcontrib>de Quatrebarbes, J.</creatorcontrib><creatorcontrib>Reynaud-Hautin, C.</creatorcontrib><creatorcontrib>Vittecoq, O.</creatorcontrib><creatorcontrib>Le Loët, X.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goëb, V.</au><au>Berthelot, J. M.</au><au>Joly, P.</au><au>Mejjad, O.</au><au>de Quatrebarbes, J.</au><au>Reynaud-Hautin, C.</au><au>Vittecoq, O.</au><au>Le Loët, X.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leflunomide-induced subacute cutaneous lupus erythematosus</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>44</volume><issue>6</issue><spage>823</spage><epage>824</epage><pages>823-824</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><coden>BJRHDF</coden><cop>England</cop><pub>Oxford University Press</pub><pmid>15757964</pmid><doi>10.1093/rheumatology/keh586</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-0324 |
ispartof | Rheumatology (Oxford, England), 2005-06, Vol.44 (6), p.823-824 |
issn | 1462-0324 1462-0332 |
language | eng |
recordid | cdi_proquest_journals_195682846 |
source | Oxford Journals Online; Alma/SFX Local Collection |
subjects | Antirheumatic Agents - adverse effects Arthritis, Rheumatoid - drug therapy Female Humans Isoxazoles - adverse effects Lupus Erythematosus, Cutaneous - chemically induced Middle Aged |
title | Leflunomide-induced subacute cutaneous lupus erythematosus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A27%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leflunomide-induced%20subacute%20cutaneous%20lupus%20erythematosus&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Goe%CC%88b,%20V.&rft.date=2005-06-01&rft.volume=44&rft.issue=6&rft.spage=823&rft.epage=824&rft.pages=823-824&rft.issn=1462-0324&rft.eissn=1462-0332&rft.coden=BJRHDF&rft_id=info:doi/10.1093/rheumatology/keh586&rft_dat=%3Cproquest_cross%3E857798361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c407t-d89fe1e5d53e7b8dcbcf2a85a57b01a3a9521e6ded1947ee8256380a3f0f5aee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195682846&rft_id=info:pmid/15757964&rfr_iscdi=true |